Massimo Sandal

News

Reducing Risk, One Mask at a Time: What the Science Says

Author:: Massimo Sandal

Publish date: January 10, 2025

Data from studies suggest that as we prepare for potential future pandemics, it may be time to move past polarization and reintroduce masks—not as ...

News

Latest data: COVID vaccine safety, protection, and breakthrough infections in inflammatory, autoimmune diseases

Author:: Massimo Sandal

Publish date: June 15, 2023

EULAR 2023 served up a bevy of studies on the protection and safety of COVID vaccines for patients and pregnant and breastfeeding women, as well as...

News

Dazodalibep may mitigate Sjögren’s syndrome, but more data are needed

Author:: Massimo Sandal

Publish date: June 12, 2023

The novel agent targets CD40 ligand and showed promising results in a two-stage, phase 2 clinical trial, particularly for patients with notable sym...

News

EULAR PsA recommendations update emphasizes safety, nonmusculoskeletal manifestations

Author:: Massimo Sandal

Publish date: June 9, 2023

The update builds on 2019 recommendations and incorporates safety concerns about JAK inhibitors, advises on differential drug efficacy across disea...

News

Long COVID risk not higher with rheumatic diseases

Author:: Massimo Sandal

Publish date: June 8, 2023

“The data demonstrate that rheumatic disease itself is not a risk factor for long COVID. However, patients with rheumatic diseases are at a higher ...

News

Lupus nephritis: Hopes, questions arise for baricitinib

Author:: Massimo Sandal

Publish date: June 1, 2023

Results from a small, independently funded, double-blind, active-comparator trial suggest that baricitinib could be beneficial in the treatment of ...